April 2024
-
Coeptis Therapeutics’ Dave Mehalick on Making Cell Therapy Universally Accessible
April 30, 2024 — In a recent interview with InvestorNews, Dave Mehalick, Chairman, President, and CEO of Coeptis…
-
Guy Bourassa on the Armor Strength of Scandium Canada
April 29, 2024 — In a recent interview with Tracy Weslosky of InvestorNews, Guy Bourassa, CEO and Director…
-
André Larente from DIAGNOS on Transforming Optometry and Expanding AI Capabilities
April 29, 2024 — In a recent interview with InvestorNews host Tracy Weslosky, André Larente, President, CEO, and…
-
John Passalacqua on First Phosphate Meeting the Demand for Battery-Grade LFP Cathode Active Material
April 25, 2024 — In a recent InvestorNews interview, host Peter Clausi spoke with John Passalacqua, CEO and…
-
Dave Mehalick from Coeptis Therapeutics to Host InvestorTalk (04.25.2024)
InvestorNews is pleased to announce an upcoming InvestorTalk scheduled for Thursday, April 25th at 9 AM EST, featuring…
-
Andre Larente from DIAGNOS to Host InvestorTalk (04.24.2024)
InvestorNews is hosting an InvestorTalk this morning with André Larente, CEO, President, and Director from DIAGNOS Inc. (TSXV:…
-
Criticality & China: A Matter of Perspective
In the latest thinkpiece from Hallgarten & Company, editor Christopher Ecclestone analyzes the issue of critical metal and…
